🔎 Trials Near Me

Home › Osteosarcoma › Tennessee › Memphis

Osteosarcoma clinical trials in Memphis, TN

10 studies for Osteosarcoma are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

RecruitingPhase 2
  • Saint Jude Children's Research Hospital, Memphis
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

RecruitingPhase 2
  • St. Jude Children's Research Hospital, Memphis
Up to age 21 · All sexes · Updated Sep 1, 2026 · NCT07428993

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RecruitingPhase 1/2
  • Saint Jude Children's Research Hospital, Memphis
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

RecruitingPhase 3
  • Saint Jude Children's Research Hospital, Memphis
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Recruiting
  • St. Jude Children's Research Hospital, Memphis
All ages · All sexes · Updated Aug 21, 2026 · NCT07514819

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

RecruitingPhase 1/2
  • St. Jude Children's Research Hospital, Memphis
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

RecruitingObservational studyHealthy volunteers welcome
  • St. Jude Children's Research Hospital, Memphis
Ages 5 to 20 · All sexes · Updated Jun 18, 2026 · NCT07502885

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

RecruitingPhase 1/2
  • St. Jude Children's Research Hospital, Memphis
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

RecruitingPhase 1
  • St. Jude Children's Research Hospital, Memphis
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04897321

Molecular Analysis Of Solid Tumors

RecruitingObservational study
  • St. Jude Children's Research Hospital, Memphis
Up to age 25 · All sexes · Updated Nov 12, 2025 · NCT01050296

Osteosarcoma trials in other cities

Other studies in Memphis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.